InMed Pharmaceuticals Inc. (INM) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$7.77M | -11.2% |
| 2024 | -$6.99M | +4.1% |
| 2023 | -$7.28M | +53.3% |
| 2022 | -$15.58M | -59.2% |
| 2021 | -$9.79M | -32.8% |
| 2020 | -$7.37M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$7.77M | -11.2% |
| 2024 | -$6.99M | +4.1% |
| 2023 | -$7.28M | +53.3% |
| 2022 | -$15.58M | -59.2% |
| 2021 | -$9.79M | -32.8% |
| 2020 | -$7.37M | — |